60
Participants
Start Date
August 2, 2021
Primary Completion Date
November 5, 2024
Study Completion Date
November 8, 2024
'Penny' via Memora Platform
"The overall objective of this study is to evaluate the feasibility and safety of a novel SMS text- based intervention of an Algorithmically Driven Augmented Intelligence chatbot, Penny. This chat bot will walk patients through how and when to take their oral chemotherapies, as well as provide real-time management of side effects Grade II or less, and escalate to the clinical team side effects of Grade III or more, as based on the Common Terminology Criteria for Adverse Events (CTCAE), for patients that have a gastrointestinal (GI) cancer."
Abramson Cancer Center, Philadelphia
Abramson Cancer Center at Penn Medicine
OTHER